Calyan Cardiac Therapeutics India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 08-07-2024
- Paid Up Capital ₹ 3.00 M
as on 08-07-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Calyan Cardiac Therapeutics India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Patel and Rengarajan Kumar serve as directors at the Company.
- CIN/LLPIN
U73100TN2019PTC130288
- Company No.
130288
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Calyan Cardiac Therapeutics India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Patel  | Director | 02-Jul-2019 | Current |
Rengarajan Kumar  | Director | 02-Jul-2019 | Current |
Financial Performance of Calyan Cardiac Therapeutics India.
Calyan Cardiac Therapeutics India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Calyan Cardiac Therapeutics India?
Unlock access to Calyan Cardiac Therapeutics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Qualcare Health Solutions Private LimitedActive 12 years 5 monthsRengarajan Kumar is a mutual person
Aalam Holdings And Investments Private LimitedActive 3 years 25 daysRengarajan Kumar is a mutual person
- A2 Consulting And Projects Private LimitedActive 18 years 9 months
Rengarajan Kumar is a mutual person
- Clarity Authentication Systems Private LimitedActive 5 years 4 months
Rengarajan Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Calyan Cardiac Therapeutics India?
Unlock and access historical data on people associated with Calyan Cardiac Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calyan Cardiac Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calyan Cardiac Therapeutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
